Food from Cloned Animals
By Osagie K. Obasogie and Pete Shanks,
San Francisco Chronicle
| 10. 05. 2007
A Bait and Switch?
Californians should be allowed to know what they're eating. That's the simple reason why Gov. Arnold Schwarzenegger should sign SB63, the nation's first law requiring food from cloned animals to be labeled. But there are other reasons to go slow on this unproven technology, some of which have not received the attention they deserve.
Meat and milk from cloned animals are not yet available. But the Food and Drug Administration is about to allow them into America's food chain, contrary to both scientific evidence and public sentiment. The FDA issued a draft risk assessment in December 2006 that suggested food from cloned animals presents no serious safety issues. But this was discredited by a March 2007 report by the Center for Food Safety that exposed embarrassing inadequacies in the FDA's review; there are no peer-reviewed safety studies on meat from cloned cows, pigs or goats and only three inconclusive ones on milk. Even the National Academies of Science - the government's science adviser - has said that it's just not possible to adequately assess this foods' safety.
People find food...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...